AS
Albert Seymour
See Remarks

Albert Seymour insider trades: Homology Medicines (FIXX) stock sales

See Remarks, Homology Medicines Last trade Sep 6, 2023 21 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2019
1
Company
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Albert reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 6, 2023FIXX↓ Sell$2K
Jan 9, 2023FIXX↓ Sell$5K
Jan 5, 2022FIXX↓ Sell$6K
Jan 7, 2021FIXX↓ Sell$181K
Jan 5, 2021FIXX↓ Sell$114K
Jan 2, 2020FIXX↓ Sell$187K
Dec 2, 2019FIXX↓ Sell$300K
Oct 1, 2019FIXX↓ Sell$162K
Sep 3, 2019FIXX↓ Sell$174K
Aug 1, 2019FIXX↓ Sell$162K
Jul 1, 2019FIXX↓ Sell$177K
Jun 3, 2019FIXX↓ Sell$185K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Albert Seymour's insider trades

Albert Seymour is See Remarks at Homology Medicines (FIXX). Since Jun 3, 2019, Albert has reported no open-market purchases and 12 sales worth $1.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (8 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FIXX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.